Postma D S, Koëter G H, Keyzer J J, Meurs H
J Allergy Clin Immunol. 1986 Mar;77(3):471-7. doi: 10.1016/0091-6749(86)90182-x.
In order to study the mechanism underlying early morning dyspnea in patients with chronic airflow obstruction, the relation was assessed between the diurnal variation of FEV1, plasma and urinary catecholamines, and urinary histamine (metabolites) in eight nonallergic patients (mean age, 53 years). These parameters were measured both after administration of placebo and slow-release terbutaline tablets during 1 week. The fall in FEV1 at 4 A.M. coincided with a fall in both plasma and urinary epinephrine levels, whereas no correlation between pulmonary function and norepinephrine levels was observed. Histamine and N tau -methylhistamine excretion were found within the normal range without a circadian rhythm, suggesting no important role for histamine in the occurrence of early morning dyspnea in this nonallergic patient group. Administration of slow-release terbutaline during 1 week prevented the nocturnal fall in FEV1. Terbutaline treatment suppressed plasma and urinary levels of epinephrine significantly without any effect on norepinephrine. We conclude that epinephrine appears to be an important factor in the regulation of the bronchial smooth muscle tone in patients with early morning dyspnea.
为研究慢性气流阻塞患者清晨呼吸困难的潜在机制,对8名非过敏性患者(平均年龄53岁)的第一秒用力呼气容积(FEV1)、血浆和尿儿茶酚胺以及尿组胺(代谢产物)的昼夜变化之间的关系进行了评估。在1周内分别给予安慰剂和缓释特布他林片后,对这些参数进行了测量。凌晨4点时FEV1的下降与血浆和尿肾上腺素水平的下降同时出现,而未观察到肺功能与去甲肾上腺素水平之间存在相关性。组胺和N-甲基组胺排泄量在正常范围内,且无昼夜节律,提示组胺在该非过敏性患者组清晨呼吸困难的发生中不起重要作用。在1周内给予缓释特布他林可防止夜间FEV1下降。特布他林治疗显著抑制了血浆和尿肾上腺素水平,而对去甲肾上腺素无任何影响。我们得出结论,肾上腺素似乎是清晨呼吸困难患者支气管平滑肌张力调节中的一个重要因素。